Skip to main content
. 2023 Oct 10;13(42):29749–29767. doi: 10.1039/d3ra05799b

The probable molecular targets for compounds 5d and 6.

Compound no. The probable molecular targets
5d PIK3CB (PI3-kinase p110-beta subunit)
PIK3CA (PI3-kinase p110-alpha subunit)
F9 (coagulation factor IX)
PPID (peptidyl-prolyl cistrans isomerase D)
MAOB (monoamine oxidase B)
GSK3B (glycogen synthase kinase-3 beta)
CHRM4 (muscarinic acetylcholine receptor M4)
ITK (tyrosine-protein kinase ITK/TSK)
MMP13 (matrix metalloproteinase 13)
ADORA1 (adenosine A1 receptor)a
ADORA3 (adenosine A3 receptor)
ABL1 (tyrosine-protein kinase ABL)
GABRA2 (GABA receptor alpha-2 subunit)
STK17B (serine/threonine-protein kinase 17B)
STK17A (serine/threonine-protein kinase 17A)
6 EDNRA/B (endothelin receptor ET-A/B)
SCN9A (sodium channel protein type IX alpha subunit)
TBXA2R (thromboxane A2 receptor)
EPHX1 (epoxide hydrolase 1)
AURKA/B (serine/threonine-protein kinase Aurora-A/B)
MAPK8 (c-Jun N-terminal kinase 1)
MAPK10 (c-Jun N-terminal kinase 3)
JAK1/2 (tyrosine-protein kinase JAK1/2)
PTGS2 (cyclooxygenase-2)
ESR2 (estrogen receptor beta)
IMPDH2 (inosine-5′-monophosphate dehydrogenase 2)
ADORA1 (adenosine A1 receptor)a
a

The common probable molecular target for compounds 5d and 6.